Familial leukemia is rate, but, as is the case with other cancer famil
y syndromes, its study is likely to lead to the identification of gene
s causative of the far more common, sporadic cases. I review the clini
cal and, what is known of the molecular genetic features of familial l
eukemia. I propose a nosology based on whether the leukemia is a compo
nent of a medical syndrome or exists as a solitary disease, the appare
nt mode of inheritance, and the distribution of leukemia types and sub
types in affected family members. I review the recent findings from my
group that leukemia is inherited with 'anticipation', in the form of
a declining age of onset with each passing generation. I consider two
models of leukemia genesis that can potentially account for anticipati
on in familial cases and incorporate epidemiological observations made
in sporadic cases. The first model is analogous to trinucleotide repe
at expansion in Huntington disease, myotonic dystrophy, and other inhe
rited neurodegenerative illness demonstrating anticipation. The second
model considers evidence that anticipation may be common to multiple
types of familial cancer and is based on the intergenerational inherit
ance of multiple downstream mutations resulting from a defect in a sin
gle DNA repair gene.